Clinical trial
Bone Resorption, Osteoclastogenesis and Adalimumab
NCT02035800 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bone Resorption, Osteoclastogenesis and Adalimumab
- Lead sponsor
- Université de Sherbrooke
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2013
- Completion date
- December 31, 2019
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis